Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01289275 · ClinicalTrials.gov registry record · Phase 4
Smoking Cessation in Hospitalized Smokers
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,270
- Enrollment target
NCT01289275: Completed Phase 4 study, sponsored by University of California, San Diego.
NCT01289275 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 1,270 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (145% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01289275, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,270 participants
- Enrollment target
Study Summary
When smokers are hospitalized they quit smoking, either voluntarily or involuntarily. Most of them, however, go back to smoking soon after discharge. This study will test an innovative approach which includes dispensing nicotine patches at discharge, providing proactive telephone counseling post discharge, or giving a combination of the two. The interventions are aimed at increasing the long term quit rate of these patients. The specific aims of the study are to demonstrate the effects of two interventions, dispensing nicotine patches at discharge and providing proactive telephone counseling soon after discharge, on 12-month quit rates of hospitalized smokers in a 2 x 2 factorial design.
Primary Outcome
All participants will receive an assessment Interview 6-months after their initial contact with the Helpline. The interview will cover, as appropriate, tobacco use, use of quitting aids, pattern of quitting (including slips and relapse situations), and satisfaction with the services. The interview will be conducted over the telephone. Intention to treat analysis.
Interventions
- DRUG Nicotine Patches
- BEHAVIORAL Telephone Counseling
- BEHAVIORAL Brief Hospital Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,270 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 4 |
What the finished NCT01289275 record still lists
NCT01289275 is an interventional study that assigns participants to a tested intervention. Its 1,270 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (145% higher).
The record links to 0 conditions, and to 3 interventions - of which Nicotine Patches is the first listed.
NCT01289275 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01289275 about?
NCT01289275 is a clinical study titled "Smoking Cessation in Hospitalized Smokers". When smokers are hospitalized they quit smoking, either voluntarily or involuntarily. Most of them, however, go back to smoking soon after discharge. This study will test an innovative approach which includes dispensing nicotine patches at discharge, providing proactive telephone counseling post dis...
What is the current status of trial NCT01289275?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,270 participants. The study started on 2011-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01289275?
The interventions under investigation include: Nicotine Patches (DRUG), Telephone Counseling (BEHAVIORAL), Brief Hospital Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01289275?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01289275's enrollment target sits among peer trials
1,270 60th of 2000 higher than 1,940 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
- NCT06876246 · 1,270 participants · NA
SBIR/ STTR Family Check-up Online
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia